Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 37290468

Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2023 Jul
First author
Liu LT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Jul;24(7):713-715. doi: 10.1016/S1470-2045(23)00266-8.
    note
    Source null
    related pmid
    37290469
    relationship
    Comment in

Authors and identifiers

  1. name
    Liu LT
    type
    Author
  2. name
    Liu H
    type
    Author
  3. name
    Huang Y
    type
    Author
  4. name
    Yang JH
    type
    Author
  5. name
    Xie SY
    type
    Author
  6. name
    Li YY
    type
    Author
  7. name
    Guo SS
    type
    Author
  8. name
    Qi B
    type
    Author
  9. name
    Li XY
    type
    Author
  10. name
    Chen DP
    type
    Author
  11. name
    Jin F
    type
    Author
  12. name
    Sun XS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Liu LT
    type
    Author
  2. name
    Liu H
    type
    Author
  3. name
    Huang Y
    type
    Author
  4. name
    Yang JH
    type
    Author
  5. name
    Xie SY
    type
    Author
  6. name
    Li YY
    type
    Author
  7. name
    Guo SS
    type
    Author
  8. name
    Qi B
    type
    Author
  9. name
    Li XY
    type
    Author
  10. name
    Chen DP
    type
    Author
  11. name
    Jin F
    type
    Author
  12. name
    Sun XS
    type
    Author
bibliography ids
  1. nci-bib-e5deb1598eccb3d15ce3ce40
book metadata
content sha256
b9025ee293bd346d33ca5ed08171e5a9337f56009b3388a37c7c82f6d425cfe4
document type
citation
dois
  1. 10.1016/S1470-2045(23)00232-2
electronic publication date
display
2023 Jun 5
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:37290468
immutable id
pubmed:37290468@b9025ee293bd346d33ca5ed08171e5a9337f56009b3388a37c7c82f6d425cfe4
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
7
name
The Lancet. Oncology
nlm unique id
100957246
pages
798-810
volume
24
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2023 Jul;24(7):713-715. doi: 10.1016/S1470-2045(23)00266-8.
    note
    Source null
    related pmid
    37290469
    relationship
    Comment in
outcomes validated
false
pmid
37290468
provenance
batch id
5329a5d0877ee70ecd11
provider
NCBI PubMed ESummary
record sha256
3f80e64b923aa1dfafb9055274403958c61e8f183701e0b4a6823b9246e6b8c3
response sha256
bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
retrieved at
2026-09-09T23:48:15.763286+00:00
publication date
display
2023 Jul
precision
month
year
2023
publication types
  1. Randomized Controlled Trial
  2. Multicenter Study
  3. Clinical Trial, Phase III
  4. Journal Article
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/37290468/
title
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.

Preserved source evidence · Not medical advice